Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/78892
PIRA download icon_1.1View/Download Full Text
DC FieldValueLanguage
dc.contributorDepartment of Applied Biology and Chemical Technologyen_US
dc.contributorChinese Mainland Affairs Officeen_US
dc.creatorZhou, LPen_US
dc.creatorWong, KYen_US
dc.creatorYeung, HTen_US
dc.creatorDong, XLen_US
dc.creatorXiao, HHen_US
dc.creatorGong, AGWen_US
dc.creatorTsim, KWKen_US
dc.creatorWong, MSen_US
dc.date.accessioned2018-10-26T01:21:32Z-
dc.date.available2018-10-26T01:21:32Z-
dc.identifier.urihttp://hdl.handle.net/10397/78892-
dc.language.isoenen_US
dc.publisherFrontiers Research Foundationen_US
dc.rightsCopyright © 2018 Zhou, Wong, Yeung, Dong, Xiao, Gong, Tsim and Wong. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.en_US
dc.rightsThe following publication Zhou L-P, Wong K-Y, Yeung H-T, Dong X-L, Xiao H-H, Gong AG-W, Tsim KW-K and Wong M-S (2018) Bone Protective Effects of Danggui Buxue Tang Alone and in Combination With Tamoxifen or Raloxifene in vivo and in vitro. Front. Pharmacol. 9:779 is available at https://dx.doi.org/10.3389/fphar.2018.00779en_US
dc.subjectDanggui Buxue Tangen_US
dc.subjectSERMsen_US
dc.subjectPostmenopausal osteoporosisen_US
dc.subjectInteractionsen_US
dc.subjectEstrogen receptoren_US
dc.titleBone protective effects of Danggui Buxue Tang alone and in combination with tamoxifen or raloxifene in vivo and in vitroen_US
dc.typeJournal/Magazine Articleen_US
dc.identifier.volume9en_US
dc.identifier.doi10.3389/fphar.2018.00779en_US
dcterms.abstractDanggui Buxue Tang (DBT), a traditional Chinese Medicine decoction containing Astragali Radix (AR) and Angelicae Sinensis Radix (ASR), is commonly prescribed for women in China as a remedy for menopausal symptoms. Previous study indicated that DBT stimulated cell growth and differentiation of human osteosarcoma MG-63 cells and exhibited estrogenic properties via estrogen receptors (ERs). The present study aimed to study the bone protective effects of DBT and its potential interactions with selective estrogen receptor modulators (SERMs, tamoxifen and raloxifene) in both in vivo and in vitro models as they act via similar ERs. Six-month-old Sprague-Dawley rats were randomly assigned to the following treatments for 12 weeks: (1) shamoperated control group with vehicle (sham), (2) ovariectomized group with vehicle (OVX), (3) OVX with 17 beta-estradiol (E2, 2.0 mg/kg day), (4) OVX with tamoxifen (Tamo, 1.0 mg/kg day), (5) OVX with raloxifene (Ralo, 3.0 mg/kg day), (6) OVX with DBT (DBT, 3.0 g/kg day), (7) OVX with DBT + Tamoxifen (DBT + Tamo), and (8) OVX with DBT + Raloxifene (DBT + Ralo). Effects of DBT and potential interactions between DBT and SERMs were also evaluated in MG-63 cells. DBT, tamoxifen, raloxifene, and their combinations significantly increased bone mineral density (BMD) and improved trabecular bone properties, including bone surface (BS), trabecular bone number (Tb.N), and trabecular bone separation (Tb.Sp), as well as restored changes in bone turnover biomarkers and mRNA expression of genes involved in bone metabolism in OVX rats. Furthermore, DBT, SERMs, and their combinations significantly increased serum estradiol and suppressed follicle stimulating hormone and luteinizing hormone in OVX rats, suggesting the possible involvement of the hypothalamus-pituitary-gonadal axis in mediating their bone protective effects. However, SERMs, but not DBT, significantly increased uterus index in OVX rats. DBT significantly induced ALP activity and estrogen response element-dependent transcription in MG-63 cells. Our study demonstrated that DBT alone and in combinations with SERMs could exert bone protective effects in vitro and in vivo.en_US
dcterms.accessRightsopen accessen_US
dcterms.bibliographicCitationFrontiers in pharmacology, Aug. 2018, v. 9, 779en_US
dcterms.isPartOfFrontiers in pharmacologyen_US
dcterms.issued2018-08-
dc.identifier.isiWOS:000441408300001-
dc.identifier.scopus2-s2.0-85051641079-
dc.identifier.eissn1663-9812en_US
dc.identifier.artn779en_US
dc.description.validate201810 bcrcen_US
dc.description.oaVersion of Recorden_US
dc.identifier.FolderNumberOA_IR/PIRA, a1375-
dc.identifier.SubFormID44727-
dc.description.fundingSourceRGCen_US
dc.description.fundingSourceOthersen_US
dc.description.fundingTextOthers: Health and Medical Research Fund (HMRF) grant (Ref. No. 11122111);Research Studentship support (RTKT) for L-PZ at The Hong Kong Polytechnic University;Shenzhen Basic Research Program (JCYJ20140819153305696);Major International (Regional) Joint Research Program of China, National Natural Science Foundation of China (81220108028);Hong Kong RGC GRF (662713)en_US
dc.description.pubStatusPublisheden_US
Appears in Collections:Journal/Magazine Article
Files in This Item:
File Description SizeFormat 
fphar-09-00779.pdf3.33 MBAdobe PDFView/Open
Open Access Information
Status open access
File Version Version of Record
Access
View full-text via PolyU eLinks SFX Query
Show simple item record

Page views

119
Last Week
0
Last month
Citations as of Apr 14, 2024

Downloads

22
Citations as of Apr 14, 2024

SCOPUSTM   
Citations

26
Citations as of Apr 19, 2024

WEB OF SCIENCETM
Citations

26
Last Week
0
Last month
Citations as of Apr 18, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.